Coronary Artery Calcification, Cardiovascular Events, and Death: A Prospective Cohort Study of Incident Patients on Hemodialysis

Canadian Journal of Kidney Health and Disease - Tập 2 - Trang 65 - 2015
Trevor J. Wilkieson1, Mozibur Rahman2, Azim S. Gangji1, Michael Voss3, Alistair J. Ingram1, Nischal Ranganath1, Charlie H. Goldsmith2,4, Cathy Z. Kotsamanes1, Mark Crowther1, Christian G. Rabbat1, Catherine M. Clase1
1Department of Medicine, McMaster University, 50 Charlton Avenue East, Hamilton, L8N4A6, ON, Canada
2Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada
3Department of Radiology, McMaster University, Hamilton, Canada
4Faculty of Health Sciences, Simon Fraser University and Arthritis Research Centre of Canada, Richmond, Canada

Tóm tắt

Background: Coronary calcification in patients with end-stage renal disease (ESRD) is associated with an increased risk of cardiovascular outcomes and death from all causes. Previous evidence has been limited by short follow-up periods and inclusion of a heterogeneous cluster of events in the primary analyses. Objective: To describe coronary calcification in patients incident to ESRD, and to identify whether calcification predicts vascular events or death. Design: Prospective substudy of an inception cohort. Setting: Tertiary care haemodialysis centre in Ontario (St Joseph's Healthcare Hamilton). Participants: Patients starting haemodialysis who were new to ESRD. Measurements: At baseline, clinical characterization and spiral computed tomography (CT) to score coronary calcification by the Agatston-Janowitz 130 scoring method. A primary outcome composite of adjudicated stroke, myocardial infarction, or death. Methods: We followed patients prospectively to identify the relationship between cardiac calcification and subsequent stroke, myocardial infarction, or death, using Cox regression. Results: We recruited 248 patients in 3 centres to our main study, which required only biochemical markers. Of these 164 were at St Joseph's healthcare, and eligible to participate in the substudy; of these, 51 completed CT scanning (31 %). Median follow up was 26 months (Q1, Q3: 14, 34). The primary outcome occurred in 16 patients; 11 in the group above the median and 5 in the group below ( p = 0.086). There were 26 primary outcomes in 16 patients; 20 (77 %) events in the group above the coronary calcification median and 6 (23 %) in the group below ( p = 0.006). There were 10 deaths; 8 in the group above the median compared with 2 in the group below ( p = 0.04). The hazard ratios for coronary calcification above, compared with below the median, for the primary outcome composite were 2.5 (95 % CI 0.87, 7.3; p = 0.09) and 1.7 (95 % CI 0.55, 5.4; p = 0.4), unadjusted and adjusted for age, respectively. For death, the hazard ratios were 4.6 (95 % CI 0.98, 21.96; p = 0.054) and 2.4 (95 % CI 0.45, 12.97; p = 0.3) respectively. Limitations: We were limited by a small sample size and a small number of events. Conclusions: Respondent burden is high for additional testing around the initiation of dialysis. High coronary calcification in patients new to ESRD has a tendency to predict cardiovascular outcomes and death, though effects are attenuated when adjusted for age.

Từ khóa


Tài liệu tham khảo

Canadian Organ Replacement Register, 2010, Treatment of End-Stage Organ Failure in Canada 1999 to 2008: 2010 Annual Report

United States Renal Data System, 2010, 2010 Annual Data Report

Nakamura S, 2009, Clin J Am Soc Nephrol, 4, 1892, 10.2215/CJN.04320709

Komaba H, 2010, Kidney Int, 77, 292, 10.1038/ki.2009.466

Bhan I, 2009, Clin J Am Soc Nephrol, 4, S102, 10.2215/CJN.04800709

Mehrotra R, 2004, Kidney Int, 66, 2022, 10.1111/j.1523-1755.2004.00974.x

Shantouf R, 2009, Clin J Am Soc Nephrol, 4, 1106, 10.2215/CJN.06091108

Ohtake T, 2010, Hemodial Int, 14, 218, 10.1111/j.1542-4758.2009.00423.x

Coen G, 2010, BMC Nephrol, 11, 10, 10.1186/1471-2369-11-10

Caliskan Y, 2010, Nephrol Dial Transplant, 25, 2685, 10.1093/ndt/gfq113

Matsuoka M, 2004, Clin Exp Nephrol, 8, 54, 10.1007/s10157-003-0260-0

Watanabe R, 2010, Clin J Am Soc Nephrol, 5, 189, 10.2215/CJN.06240909

Speigel DM, 2007, Nephrol Dial Transplant, 22, 3568, 10.1093/ndt/gfm424

Block GA, 2005, Kidney Int, 68, 1815, 10.1111/j.1523-1755.2005.00600.x

Block GA, 2007, Kidney Int, 71, 438, 10.1038/sj.ki.5002059

Moe SM, 2003, Nephrol Dial Transplant, 18, 1152, 10.1093/ndt/gfg093

Janowitz WR, 2003, Semin Roentgenol, 38, 309, 10.1016/S0037-198X(03)00058-0

Tuttle KR, 2009, Clin J Am Soc Nephrol, 4, 1968, 10.2215/CJN.01250209

Thông tin
Thông tin xuất bản

Canadian Journal of Kidney Health and Disease

Tập 2

65

Thông tin tác giả